Medicine on Trial: The Appalling Story of Ineptitude, Malfeasance, Neglect, and Arrogance

(5)
Medicine on Trial: The Appalling Story of Ineptitude, Malfeasance, Neglect, and Arrogance image
ISBN-10:

0135735440

ISBN-13:

9780135735442

Edition: First Edition
Released: Jan 01, 1988
Format: Hardcover, 304 pages

Description:

This expose of medical incompetence reveals diagnosis errors, greed, unnecessary surgery, and substance abuse found among the nation's physicians and the profession's callous disregard for the patients' needs

Best prices to buy, sell, or rent ISBN 9780135735442




Related Books

Frequently Asked Questions about Medicine on Trial: The Appalling Story of Ineptitude, Malfeasance, Neglect, and Arrogance

You can buy the Medicine on Trial: The Appalling Story of Ineptitude, Malfeasance, Neglect, and Arrogance book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $6.06 on Amazon and is available from 34 sellers at the moment.

At BookScouter, the prices for the book start at $1.99. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.

If you’re interested in selling back the Medicine on Trial: The Appalling Story of Ineptitude, Malfeasance, Neglect, and Arrogance book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Medicine on Trial: The Appalling Story of Ineptitude, Malfeasance, Neglect, and Arrogance book, the best buyback offer comes from and is $ for the book in good condition.

The Medicine on Trial: The Appalling Story of Ineptitude, Malfeasance, Neglect, and Arrogance book is in very low demand now as the rank for the book is 3,688,111 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.